SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-24-003882
Filing Date
2024-05-30
Accepted
2024-05-30 16:05:04
Documents
1
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4853
  Complete submission text file 0001683168-24-003882.txt   7008
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Reporting) CIK: 0001157075 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 0430
Type: 3 | Act: 34 | File No.: 001-36268 | Film No.: 241005154
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)